Medpace (MEDP) to Release Earnings on Monday

Medpace (NASDAQ:MEDP - Get Free Report) is expected to be releasing its earnings data after the market closes on Monday, February 10th. Analysts expect Medpace to post earnings of $2.96 per share and revenue of $535.01 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.

Medpace Price Performance

Shares of Medpace stock traded up $5.82 on Thursday, reaching $360.97. The company had a trading volume of 262,273 shares, compared to its average volume of 217,324. The firm's 50-day moving average price is $343.17 and its two-hundred day moving average price is $350.31. Medpace has a 1 year low of $301.81 and a 1 year high of $459.77. The firm has a market cap of $11.22 billion, a price-to-earnings ratio of 31.61, a P/E/G ratio of 1.79 and a beta of 1.36.

Analysts Set New Price Targets

Several research firms have issued reports on MEDP. Truist Financial lowered their price objective on shares of Medpace from $415.00 to $397.00 and set a "hold" rating for the company in a research report on Monday, October 14th. William Blair reissued an "outperform" rating on shares of Medpace in a research note on Tuesday, October 22nd. Redburn Atlantic initiated coverage on Medpace in a research report on Monday, October 14th. They set a "buy" rating and a $404.00 target price for the company. Baird R W downgraded Medpace from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, October 23rd. Finally, TD Cowen decreased their price objective on Medpace from $413.00 to $372.00 and set a "buy" rating for the company in a report on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $381.44.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.